R1 RCM (NASDAQ:RCM) Trading Down 5.7%

Share on StockTwits

R1 RCM Inc (NASDAQ:RCM) traded down 5.7% on Friday . The company traded as low as $11.57 and last traded at $11.66, 702,894 shares were traded during mid-day trading. A decline of 26% from the average session volume of 952,083 shares. The stock had previously closed at $12.37.

A number of analysts recently weighed in on the company. ValuEngine downgraded R1 RCM from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 1st. BidaskClub upgraded R1 RCM from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 3rd. Finally, Zacks Investment Research downgraded R1 RCM from a “buy” rating to a “hold” rating in a report on Tuesday, August 13th. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $14.80.

The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of -36.44 and a beta of 0.09. The stock has a fifty day moving average of $12.58 and a two-hundred day moving average of $11.18. The company has a debt-to-equity ratio of 106.30, a current ratio of 0.90 and a quick ratio of 0.90.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings data on Tuesday, August 6th. The financial services provider reported ($0.09) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.08). The company had revenue of $295.00 million during the quarter, compared to analyst estimates of $294.11 million. R1 RCM had a negative net margin of 2.22% and a negative return on equity of 249.01%. The business’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.07) earnings per share. On average, research analysts forecast that R1 RCM Inc will post -0.01 EPS for the current year.

In related news, Director Charles J. Ditkoff sold 4,099 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $11.72, for a total value of $48,040.28. Following the completion of the sale, the director now directly owns 4,099 shares in the company, valued at $48,040.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 59.40% of the company’s stock.

Institutional investors have recently modified their holdings of the business. Bank of America Corp DE grew its holdings in R1 RCM by 71.6% during the 4th quarter. Bank of America Corp DE now owns 323,451 shares of the financial services provider’s stock worth $2,571,000 after acquiring an additional 134,974 shares during the period. Cadence Capital Management LLC grew its stake in shares of R1 RCM by 18.0% in the 1st quarter. Cadence Capital Management LLC now owns 369,918 shares of the financial services provider’s stock valued at $3,577,000 after buying an additional 56,302 shares during the period. Bailard Inc. acquired a new stake in shares of R1 RCM in the 1st quarter valued at about $242,000. Insight Wealth Strategies LLC grew its stake in shares of R1 RCM by 4.7% in the 2nd quarter. Insight Wealth Strategies LLC now owns 185,928 shares of the financial services provider’s stock valued at $2,339,000 after buying an additional 8,357 shares during the period. Finally, Hennessy Advisors Inc. acquired a new stake in shares of R1 RCM in the 2nd quarter valued at about $3,589,000. Hedge funds and other institutional investors own 70.20% of the company’s stock.

R1 RCM Company Profile (NASDAQ:RCM)

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Featured Article: Outstanding Shares and The Effect on Share Price

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

-$0.61 EPS Expected for Titan Medical Inc.  This Quarter
-$0.61 EPS Expected for Titan Medical Inc. This Quarter
$70.20 Million in Sales Expected for New Age Beverages Corp  This Quarter
$70.20 Million in Sales Expected for New Age Beverages Corp This Quarter
Spark New Zealand Ltd  Plans Dividend Increase – $0.37 Per Share
Spark New Zealand Ltd Plans Dividend Increase – $0.37 Per Share
Ares Dynamic Credit Allocation Fund Inc  To Go Ex-Dividend on September 18th
Ares Dynamic Credit Allocation Fund Inc To Go Ex-Dividend on September 18th
Wells Fargo & Co Cuts Baker Hughes A GE  Price Target to $30.00
Wells Fargo & Co Cuts Baker Hughes A GE Price Target to $30.00
QAD Inc.  to Issue Quarterly Dividend of $0.07
QAD Inc. to Issue Quarterly Dividend of $0.07


 
© 2006-2019 Zolmax.